Imagion Biosystems Limited

ASX (AUD): Imagion Biosystems Limited (IBX)

Last Price

0.017

Today's Change

-0.003 (15.00%)

Day's Change

0.017 - 0.02

Trading Volume

3,281,427

Overview

Market Cap

3 Million

Shares Outstanding

201 Million

Avg Volume

1,532,627

Avg Price (50 Days)

0.02

Avg Price (200 Days)

0.04

PE Ratio

-0.09

EPS

-0.18

Earnings Announcement

28-Feb-2025

Previous Close

0.02

Open

0.02

Day's Range

0.017 - 0.02

Year Range

0.015 - 0.097

Trading Volume

3,281,427

Price Change Highlight

1 Day Change

-15.00%

5 Day Change

-5.56%

1 Month Change

-10.53%

3 Month Change

-52.78%

6 Month Change

-56.41%

Ytd Change

-19.05%

1 Year Change

-80.23%

3 Year Change

-99.30%

5 Year Change

-98.44%

10 Year Change

-99.68%

Max Change

-99.68%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Diagnostics & Research

Description:

Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX, an iron oxide nanoparticle to detect cancer. Imagion Biosystems Limited has a collaborative research program with Patrys Limited to use the combined technologies for enhancing brain tumor imaging and diagnosis; and a joint development agreement with Global Cancer Technology, Inc. to develop GCT's novel nanoscintillator technology for the treatment of breast cancer. The company was incorporated in 2016 and is based in San Diego, California.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment